Publication at Faculty of Medicine in Hradec Králové |
2016
Abstract
Multiple sclerosis is a chronic inflammatory demyelinating disease which affect central nervous system. This autoimmune disease manifests itself with various symptoms.
Glatiramer acetate (Copaxone) is a drug of the the first line treatment for relaps/remitent type of multiple sclerosis or clinically isolated syndrome. This review explore the mechanism of action of glatiramer acetate in treatment of multiple sclerosis, its indication for treatment, use and possible side effects too.
We report three cases from our own patients base through we demonstrate possible use of glatiramer acetate.